Tmem119 has been reported to be IHC-positive in microglia but not in peripheral immune cells (Bennett et al., 2016) and was used to distinguish resident microglia from migrated peripheral cells in Alzheimer’s disease (Satoh et al., 2016) and glioma (Haage et al., 2019). Here, TMEM119 is linked to central nervous system cancer.